Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Abivax (AAVXF) Current Assets (2022 - 2025)

Historic Current Assets for Abivax (AAVXF) over the last 4 years, with Q3 2025 value amounting to $724.0 million.

  • Abivax's Current Assets changed N/A to $724.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $724.0 million, marking a year-over-year change of. This contributed to the annual value of $182.4 million for FY2024, which is 4104.3% down from last year.
  • Latest data reveals that Abivax reported Current Assets of $724.0 million as of Q3 2025.
  • Abivax's 5-year Current Assets high stood at $724.0 million for Q3 2025, and its period low was $36.9 million during Q4 2022.
  • Over the past 4 years, Abivax's median Current Assets value was $182.4 million (recorded in 2024), while the average stood at $250.0 million.
  • As far as peak fluctuations go, Abivax's Current Assets skyrocketed by 73353.82% in 2023, and later crashed by 6275.27% in 2025.
  • Quarter analysis of 4 years shows Abivax's Current Assets stood at $36.9 million in 2022, then soared by 733.54% to $307.7 million in 2023, then crashed by 40.73% to $182.4 million in 2024, then surged by 296.97% to $724.0 million in 2025.
  • Its Current Assets was $724.0 million in Q3 2025, compared to $97.5 million in Q2 2025 and $139.6 million in Q1 2025.